Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Kirin Holdings Co Ltd    2503   JP3258000003

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Kirin Holdings Co., Ltd. is engaged in the manufacture and sale of beverages and pharmaceutical products.It operates through the following segments: Domestic Alcohol, Domestic Beverages, Foreign Liquor and Beverages, Pharmaceuticals and Biochemicals, and Others.The Domestic Alcohol segment includes... 
Sector
Brewers
Calendar
10/30Earnings Release
Surperformance© rating of Kirin Holdings Co Ltd
Trading Rating : Investor Rating :
More about the company
Chart KIRIN HOLDINGS CO LTD
Duration : Period :
Kirin Holdings Co Ltd Technical Analysis Chart | 2503 | JP3258000003 | 4-Traders
Full-screen chart
Financials ( JPY)
Sales 2014 2 216 644 M
EBIT 2014 111 330 M
Net income 2014 48 614 M
Debt 2014 665 858 M
Yield 2014 2,71%
Sales 2015 2 237 486 M
EBIT 2015 121 572 M
Net income 2015 59 549 M
Debt 2015 616 203 M
Yield 2015 2,90%
PER 2014 29,04
PER 2015 23,14
EV / Sales 2014 0,91x
EV / Sales 2015 0,88x
Capitalization 1 351 000 M
More Financials
Latest news on KIRIN HOLDINGS CO LTD
8h ago KYOWA HAKKO KIRIN : Completion of Construction for Drug Product Manufacturing Fa..
1d ago ULTRAGENYX PHARMACEUTICAL : Granted EU Orphan Drug Designation for KRN23 for the..
1d ago KYOWA HAKKO KIRIN : Announces Completion of Construction for Drug Product Manufa..
10/14 Pfizer and Kyowa Hakko Kirin to Partner on Immuno-Oncology Combination Study
10/08 Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination St..
10/03 Pfizer and Kyowa Hakko Kirin to Partner on Immuno-Oncology Combination Study
10/02 KIRIN : Gov. Beshear Celebrates Grand Opening of Four Roses Bourbon's New Visito..
09/29 Approval for Sustained-Duration G-CSF Product G-Lasta in Japan
09/25 KIRIN : Mercians' mission to preserve peace on island that is divided ; UN ROLE:..
09/23 KIRIN : 180 Mercians join warfare training ; ARMY
09/15 ULTRAGENYX PHARMACEUTICAL : Announces Positive Results From a Long-Term Phase 1/..
09/01 Kyowa Hakko Kirin Announces Commencement of Phase 2b Clinical Study of KHK758..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF